| 0.8993 -0.051 (-5.35%) | 08-10 16:00 | |||||||||||||
|
|
| Short term |   |
|||
| Mid term |  |
|||
| Targets | 6-month : | 1.12 |
1-year : | 1.21 |
| Resists | First : | 0.95 |
Second : | 1.03 |
| Pivot price | 0.91 |
|||
| Supports | First : | 0.82 |
Second : | 0.69 |
| MAs | MA(5) : | 0.96  |
MA(20) : | 0.92 |
| MA(100) : | 0.95 |
MA(250) : | 2.12 |
|
| MACD | MACD : | 0 |
Signal : | 0 |
| %K %D | K(14,3) : | 52.2 |
D(3) : | 69.1 |
| RSI | RSI(14): 48.2 |
|||
| 52-week | High : | 9.52 | Low : | 0.56 |
Price has closed below its short-term moving average. Short-term moving average is currently above mid-term; and above long-term moving average. From the relationship between price and moving averages: This stock is NEUTRAL in short-term; and NEUTRAL in mid-long term.[ BGMS ] has closed above bottom band by 38.4%. Bollinger Bands are 44.7% narrower than normal. The narrow width of the bands suggests low volatility as compared to its normal range. The bands have been in this narrow range for 12 bars. This is a sign that the market may be about to initiate a new trend.
| If tomorrow: | Open lower | Open higher |
| High: | 0.95 - 0.96 | 0.96 - 0.96 |
| Low: | 0.86 - 0.87 | 0.87 - 0.87 |
| Close: | 0.89 - 0.9 | 0.9 - 0.91 |
Bio Green Med Solution, Inc. (BGMS) operates as a multifaceted company, with active involvement in both the fire protection and biopharmaceutical industries. The organization recently broadened its capabilities by completing the acquisition of Fitters Sdn. Bhd., a Malaysian firm known for its fire safety products and services. BGMS is committed to driving progress in biopharmaceutical research and developing cutting-edge fire safety solutions, striving to deliver enduring value to its investors.
Fri, 07 Aug 2026
Bio Green Med Solution Ord Shs (BGMS) Earnings Forecast: Future EPS & Revenue Growth Estimates - TradingKey
Fri, 24 Jul 2026
BGMS: Bio Green Med Solution, Inc. - Financial Overview - Zacks Investment Research
Fri, 24 Jul 2026
Bio Green Med Solution (NASDAQ: BGMS) sets $2B Future NRG merger and massive dilution - Stock Titan
Fri, 05 Jun 2026
Bio Green Med Solution (BGMS) surges after announcing all-stock business combination with Future NRG - Quiver Quantitative
Fri, 05 Jun 2026
Bio Green Med Solution Surges 172% After Announcing Deal to Acquire Malaysia Waste Tech Company - Benzinga
Thu, 04 Jun 2026
Future NRG to control Bio Green Med in all-stock merger (NASDAQ: BGMS) - Stock Titan
| Price to Book Value: P/BV, a ratio used to compare book value to its current market price, to gauge whether a stock is valued properly. |
Outperform |
| Price to Earnings: PE, the ratio for valuing a company that measures its current share price relative to its earnings per share (EPS). |
Underperform |
| Discounted cash flow: DCF, a valuation method used to estimate the value of an investment based on its expected future cash flows. |
Underperform |
| Return on Assets: ROA, indicates how profitable a company is in relation to its total assets, how efficiently uses assets to generate a profit. |
Underperform |
| Return on Equity: ROE, a measure of financial performance calculated by dividing net income by equity. a gauge of profitability and efficiency. |
Underperform |
| Debt to Equity: evaluate financial leverage, reflects the ability of equity to cover outstanding debts in the event of a business downturn. |
Underperform |
|
Exchange:
NASDAQ
|
|
|
Sector:
Healthcare
|
|
|
Industry:
Medical - Pharmaceuticals
|
|
| Shares Out | 6 (M) |
| Shares Float | 3 (M) |
| Held by Insiders | 45.2 (%) |
| Held by Institutions | 1.7 (%) |
| Shares Short | 101 (K) |
| Shares Short P.Month | 193 (K) |
| EPS | 5.03 |
| EPS Est Next Qtrly | 0 |
| EPS Est This Year | 0 |
| EPS Est Next Year | 0 |
| Book Value (p.s.) | 1.23 |
| Profit Margin | -204.2 % |
| Operating Margin | -31.7 % |
| Return on Assets (ttm) | -49.4 % |
| Return on Equity (ttm) | 20.5 % |
| Qtrly Rev. Growth | 0 % |
| Gross Profit (p.s.) | -0.1 |
| Sales Per Share | 0.27 |
| EBITDA (p.s.) | -0.81 |
| Qtrly Earnings Growth | 0 % |
| Operating Cash Flow | -2 (M) |
| Levered Free Cash Flow | -4 (M) |
| PE Ratio | 0.17 |
| PEG Ratio | 0 |
| Price to Book value | 0.73 |
| Price to Sales | 3.26 |
| Price to Cash Flow | -2.76 |
| Dividend | 36 |
| Forward Dividend | 0 |
| Dividend Yield | 4003.1% |
| Dividend Pay Date | Invalid DateTime. |
| Ex-Dividend Date | Invalid DateTime. |
|
|
|
|
|
|
|
|
|